English
简体中文
Total: £ 56.28
Published Date: 2026-04-10 | Pages: 131 | Tables: 138 | Medical Care
The global Gene Delivery System market was valued at US$ 14330 million in 2025 and is anticipated to reach US$ 77240 million by 2032, at a CAGR of 27.6% from 2026 to 2032.
Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
The gene delivery system market is experiencing rapid growth, primarily driven by advancements in gene therapy, personalized medicine, and biotechnology research. The increasing prevalence of genetic disorders, cancers, and rare diseases has fueled demand for targeted and effective gene-based treatments. Innovations in delivery vectors—such as viral systems (adenoviral, lentiviral) and non-viral methods (lipid nanoparticles, polymers, and electroporation)—are enabling more precise and efficient gene delivery. Additionally, the success of mRNA-based COVID-19 vaccines has accelerated investment and trust in nucleic acid delivery platforms. Supportive regulatory policies, increased R&D funding from both government and private sectors, and rising collaborations between pharmaceutical companies and academic institutions are further boosting the global gene delivery market.
Despite significant advancements, the gene delivery system market faces several complex challenges. One major hurdle is ensuring safe, efficient, and tissue-specific delivery of genetic material without triggering immune responses or toxicity. Viral vectors, while effective, can carry risks such as insertional mutagenesis or immunogenicity, limiting their long-term application. Non-viral vectors, on the other hand, often face limitations in transfection efficiency and stability. Manufacturing scalability and quality control also remain problematic, especially for complex delivery systems. Moreover, the high cost of gene therapies and the limited availability of clinical-grade vectors pose barriers to broader adoption, particularly in low- and middle-income countries. Navigating diverse regulatory frameworks globally adds another layer of complexity for companies operating across borders.
This report delivers a comprehensive overview of the global Gene Delivery System market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Gene Delivery System. The Gene Delivery System market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Gene Delivery System market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Gene Delivery System manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Adaptimmune
Krystal Biotech
Vertex Pharmaceuticals
CSL Behring
Segment by Type
Viral Gene Delivery System
Non-viral Gene Delivery System
Segment by Application
Neurological Diseases
Cancer
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Gene Delivery System companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Delivery System Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Viral Gene Delivery System
1.2.3 Non-viral Gene Delivery System
1.3 Market by Application
1.3.1 Global Gene Delivery System Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Neurological Diseases
1.3.3 Cancer
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Delivery System Market Perspective (2021–2032)
2.2 Global Gene Delivery System Growth Trends by Region
2.2.1 Global Gene Delivery System Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Gene Delivery System Historic Market Size by Region (2021–2026)
2.2.3 Gene Delivery System Forecasted Market Size by Region (2027–2032)
2.3 Gene Delivery System Market Dynamics
2.3.1 Gene Delivery System Industry Trends
2.3.2 Gene Delivery System Market Drivers
2.3.3 Gene Delivery System Market Challenges
2.3.4 Gene Delivery System Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Delivery System Players by Revenue
3.1.1 Global Top Gene Delivery System Players by Revenue (2021–2026)
3.1.2 Global Gene Delivery System Revenue Market Share by Players (2021–2026)
3.2 Global Top Gene Delivery System Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Gene Delivery System Revenue
3.4 Global Gene Delivery System Market Concentration Ratio
3.4.1 Global Gene Delivery System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Delivery System Revenue in 2025
3.5 Global Key Players of Gene Delivery System Head Offices and Areas Served
3.6 Global Key Players of Gene Delivery System, Products and Applications
3.7 Global Key Players of Gene Delivery System, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Gene Delivery System Breakdown Data by Type
4.1 Global Gene Delivery System Historic Market Size by Type (2021–2026)
4.2 Global Gene Delivery System Forecasted Market Size by Type (2027–2032)
5 Gene Delivery System Breakdown Data by Application
5.1 Global Gene Delivery System Historic Market Size by Application (2021–2026)
5.2 Global Gene Delivery System Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Gene Delivery System Market Size (2021–2032)
6.2 North America Gene Delivery System Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Gene Delivery System Market Size by Country (2021–2026)
6.4 North America Gene Delivery System Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Delivery System Market Size (2021–2032)
7.2 Europe Gene Delivery System Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Gene Delivery System Market Size by Country (2021–2026)
7.4 Europe Gene Delivery System Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Gene Delivery System Market Size (2021–2032)
8.2 Asia-Pacific Gene Delivery System Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Gene Delivery System Market Size by Region (2021–2026)
8.4 Asia-Pacific Gene Delivery System Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Gene Delivery System Market Size (2021–2032)
9.2 Latin America Gene Delivery System Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Gene Delivery System Market Size by Country (2021–2026)
9.4 Latin America Gene Delivery System Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Delivery System Market Size (2021–2032)
10.2 Middle East & Africa Gene Delivery System Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Gene Delivery System Market Size by Country (2021–2026)
10.4 Middle East & Africa Gene Delivery System Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biogen
11.1.1 Biogen Company Details
11.1.2 Biogen Business Overview
11.1.3 Biogen Gene Delivery System Introduction
11.1.4 Biogen Revenue in Gene Delivery System Business (2021–2026)
11.1.5 Biogen Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Gene Delivery System Introduction
11.2.4 Novartis Revenue in Gene Delivery System Business (2021–2026)
11.2.5 Novartis Recent Development
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Details
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences Gene Delivery System Introduction
11.3.4 Gilead Sciences Revenue in Gene Delivery System Business (2021–2026)
11.3.5 Gilead Sciences Recent Development
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Details
11.4.2 Sarepta Therapeutics Business Overview
11.4.3 Sarepta Therapeutics Gene Delivery System Introduction
11.4.4 Sarepta Therapeutics Revenue in Gene Delivery System Business (2021–2026)
11.4.5 Sarepta Therapeutics Recent Development
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Details
11.5.2 Alnylam Pharmaceuticals Business Overview
11.5.3 Alnylam Pharmaceuticals Gene Delivery System Introduction
11.5.4 Alnylam Pharmaceuticals Revenue in Gene Delivery System Business (2021–2026)
11.5.5 Alnylam Pharmaceuticals Recent Development
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen Gene Delivery System Introduction
11.6.4 Amgen Revenue in Gene Delivery System Business (2021–2026)
11.6.5 Amgen Recent Development
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Details
11.7.2 Spark Therapeutics Business Overview
11.7.3 Spark Therapeutics Gene Delivery System Introduction
11.7.4 Spark Therapeutics Revenue in Gene Delivery System Business (2021–2026)
11.7.5 Spark Therapeutics Recent Development
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Details
11.8.2 Akcea Therapeutics Business Overview
11.8.3 Akcea Therapeutics Gene Delivery System Introduction
11.8.4 Akcea Therapeutics Revenue in Gene Delivery System Business (2021–2026)
11.8.5 Akcea Therapeutics Recent Development
11.9 Sunway Biotech
11.9.1 Sunway Biotech Company Details
11.9.2 Sunway Biotech Business Overview
11.9.3 Sunway Biotech Gene Delivery System Introduction
11.9.4 Sunway Biotech Revenue in Gene Delivery System Business (2021–2026)
11.9.5 Sunway Biotech Recent Development
11.10 SIBIONO
11.10.1 SIBIONO Company Details
11.10.2 SIBIONO Business Overview
11.10.3 SIBIONO Gene Delivery System Introduction
11.10.4 SIBIONO Revenue in Gene Delivery System Business (2021–2026)
11.10.5 SIBIONO Recent Development
11.11 AnGes
11.11.1 AnGes Company Details
11.11.2 AnGes Business Overview
11.11.3 AnGes Gene Delivery System Introduction
11.11.4 AnGes Revenue in Gene Delivery System Business (2021–2026)
11.11.5 AnGes Recent Development
11.12 Orchard Therapeutics
11.12.1 Orchard Therapeutics Company Details
11.12.2 Orchard Therapeutics Business Overview
11.12.3 Orchard Therapeutics Gene Delivery System Introduction
11.12.4 Orchard Therapeutics Revenue in Gene Delivery System Business (2021–2026)
11.12.5 Orchard Therapeutics Recent Development
11.13 Human Stem Cells Institute
11.13.1 Human Stem Cells Institute Company Details
11.13.2 Human Stem Cells Institute Business Overview
11.13.3 Human Stem Cells Institute Gene Delivery System Introduction
11.13.4 Human Stem Cells Institute Revenue in Gene Delivery System Business (2021–2026)
11.13.5 Human Stem Cells Institute Recent Development
11.14 Adaptimmune
11.14.1 Adaptimmune Company Details
11.14.2 Adaptimmune Business Overview
11.14.3 Adaptimmune Gene Delivery System Introduction
11.14.4 Adaptimmune Revenue in Gene Delivery System Business (2021–2026)
11.14.5 Adaptimmune Recent Development
11.15 Krystal Biotech
11.15.1 Krystal Biotech Company Details
11.15.2 Krystal Biotech Business Overview
11.15.3 Krystal Biotech Gene Delivery System Introduction
11.15.4 Krystal Biotech Revenue in Gene Delivery System Business (2021–2026)
11.15.5 Krystal Biotech Recent Development
11.16 Vertex Pharmaceuticals
11.16.1 Vertex Pharmaceuticals Company Details
11.16.2 Vertex Pharmaceuticals Business Overview
11.16.3 Vertex Pharmaceuticals Gene Delivery System Introduction
11.16.4 Vertex Pharmaceuticals Revenue in Gene Delivery System Business (2021–2026)
11.16.5 Vertex Pharmaceuticals Recent Development
11.17 CSL Behring
11.17.1 CSL Behring Company Details
11.17.2 CSL Behring Business Overview
11.17.3 CSL Behring Gene Delivery System Introduction
11.17.4 CSL Behring Revenue in Gene Delivery System Business (2021–2026)
11.17.5 CSL Behring Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Gene Delivery System Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Viral Gene Delivery System
Table 3. Key Players of Non-viral Gene Delivery System
Table 4. Global Gene Delivery System Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Gene Delivery System Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Gene Delivery System Market Size by Region (US$ Million), 2021–2026
Table 7. Global Gene Delivery System Market Share by Region (2021–2026)
Table 8. Global Gene Delivery System Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Gene Delivery System Market Share by Region (2027–2032)
Table 10. Gene Delivery System Market Trends
Table 11. Gene Delivery System Market Drivers
Table 12. Gene Delivery System Market Challenges
Table 13. Gene Delivery System Market Restraints
Table 14. Global Gene Delivery System Revenue by Players (US$ Million), 2021–2026
Table 15. Global Gene Delivery System Market Share by Players (2021–2026)
Table 16. Global Top Gene Delivery System Players by Tier (Tier 1, Tier 2, and Tier 3), based on Gene Delivery System Revenue, 2025
Table 17. Ranking of Global Top Gene Delivery System Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Gene Delivery System Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Gene Delivery System, Headquarters and Area Served
Table 20. Global Key Players of Gene Delivery System, Products and Applications
Table 21. Global Key Players of Gene Delivery System, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Gene Delivery System Market Size by Type (US$ Million), 2021–2026
Table 24. Global Gene Delivery System Revenue Market Share by Type (2021–2026)
Table 25. Global Gene Delivery System Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Gene Delivery System Revenue Market Share by Type (2027–2032)
Table 27. Global Gene Delivery System Market Size by Application (US$ Million), 2021–2026
Table 28. Global Gene Delivery System Revenue Market Share by Application (2021–2026)
Table 29. Global Gene Delivery System Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Gene Delivery System Revenue Market Share by Application (2027–2032)
Table 31. North America Gene Delivery System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Gene Delivery System Market Size by Country (US$ Million), 2021–2026
Table 33. North America Gene Delivery System Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Gene Delivery System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Gene Delivery System Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Gene Delivery System Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Gene Delivery System Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Gene Delivery System Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Gene Delivery System Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Gene Delivery System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Gene Delivery System Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Gene Delivery System Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Gene Delivery System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Gene Delivery System Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Gene Delivery System Market Size by Country (US$ Million), 2027–2032
Table 46. Biogen Company Details
Table 47. Biogen Business Overview
Table 48. Biogen Gene Delivery System Product
Table 49. Biogen Revenue in Gene Delivery System Business (US$ Million), 2021–2026
Table 50. Biogen Recent Development
Table 51. Novartis Company Details
Table 52. Novartis Business Overview
Table 53. Novartis Gene Delivery System Product
Table 54. Novartis Revenue in Gene Delivery System Business (US$ Million), 2021–2026
Table 55. Novartis Recent Development
Table 56. Gilead Sciences Company Details
Table 57. Gilead Sciences Business Overview
Table 58. Gilead Sciences Gene Delivery System Product
Table 59. Gilead Sciences Revenue in Gene Delivery System Business (US$ Million), 2021–2026
Table 60. Gilead Sciences Recent Development
Table 61. Sarepta Therapeutics Company Details
Table 62. Sarepta Therapeutics Business Overview
Table 63. Sarepta Therapeutics Gene Delivery System Product
Table 64. Sarepta Therapeutics Revenue in Gene Delivery System Business (US$ Million), 2021–2026
Table 65. Sarepta Therapeutics Recent Development
Table 66. Alnylam Pharmaceuticals Company Details
Table 67. Alnylam Pharmaceuticals Business Overview
Table 68. Alnylam Pharmaceuticals Gene Delivery System Product
Table 69. Alnylam Pharmaceuticals Revenue in Gene Delivery System Business (US$ Million), 2021–2026
Table 70. Alnylam Pharmaceuticals Recent Development
Table 71. Amgen Company Details
Table 72. Amgen Business Overview
Table 73. Amgen Gene Delivery System Product
Table 74. Amgen Revenue in Gene Delivery System Business (US$ Million), 2021–2026
Table 75. Amgen Recent Development
Table 76. Spark Therapeutics Company Details
Table 77. Spark Therapeutics Business Overview
Table 78. Spark Therapeutics Gene Delivery System Product
Table 79. Spark Therapeutics Revenue in Gene Delivery System Business (US$ Million), 2021–2026
Table 80. Spark Therapeutics Recent Development
Table 81. Akcea Therapeutics Company Details
Table 82. Akcea Therapeutics Business Overview
Table 83. Akcea Therapeutics Gene Delivery System Product
Table 84. Akcea Therapeutics Revenue in Gene Delivery System Business (US$ Million), 2021–2026
Table 85. Akcea Therapeutics Recent Development
Table 86. Sunway Biotech Company Details
Table 87. Sunway Biotech Business Overview
Table 88. Sunway Biotech Gene Delivery System Product
Table 89. Sunway Biotech Revenue in Gene Delivery System Business (US$ Million), 2021–2026
Table 90. Sunway Biotech Recent Development
Table 91. SIBIONO Company Details
Table 92. SIBIONO Business Overview
Table 93. SIBIONO Gene Delivery System Product
Table 94. SIBIONO Revenue in Gene Delivery System Business (US$ Million), 2021–2026
Table 95. SIBIONO Recent Development
Table 96. AnGes Company Details
Table 97. AnGes Business Overview
Table 98. AnGes Gene Delivery System Product
Table 99. AnGes Revenue in Gene Delivery System Business (US$ Million), 2021–2026
Table 100. AnGes Recent Development
Table 101. Orchard Therapeutics Company Details
Table 102. Orchard Therapeutics Business Overview
Table 103. Orchard Therapeutics Gene Delivery System Product
Table 104. Orchard Therapeutics Revenue in Gene Delivery System Business (US$ Million), 2021–2026
Table 105. Orchard Therapeutics Recent Development
Table 106. Human Stem Cells Institute Company Details
Table 107. Human Stem Cells Institute Business Overview
Table 108. Human Stem Cells Institute Gene Delivery System Product
Table 109. Human Stem Cells Institute Revenue in Gene Delivery System Business (US$ Million), 2021–2026
Table 110. Human Stem Cells Institute Recent Development
Table 111. Adaptimmune Company Details
Table 112. Adaptimmune Business Overview
Table 113. Adaptimmune Gene Delivery System Product
Table 114. Adaptimmune Revenue in Gene Delivery System Business (US$ Million), 2021–2026
Table 115. Adaptimmune Recent Development
Table 116. Krystal Biotech Company Details
Table 117. Krystal Biotech Business Overview
Table 118. Krystal Biotech Gene Delivery System Product
Table 119. Krystal Biotech Revenue in Gene Delivery System Business (US$ Million), 2021–2026
Table 120. Krystal Biotech Recent Development
Table 121. Vertex Pharmaceuticals Company Details
Table 122. Vertex Pharmaceuticals Business Overview
Table 123. Vertex Pharmaceuticals Gene Delivery System Product
Table 124. Vertex Pharmaceuticals Revenue in Gene Delivery System Business (US$ Million), 2021–2026
Table 125. Vertex Pharmaceuticals Recent Development
Table 126. CSL Behring Company Details
Table 127. CSL Behring Business Overview
Table 128. CSL Behring Gene Delivery System Product
Table 129. CSL Behring Revenue in Gene Delivery System Business (US$ Million), 2021–2026
Table 130. CSL Behring Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
Table 134. Authors List of This Report
List of Figures
Figure 1. Gene Delivery System Picture
Figure 2. Global Gene Delivery System Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Gene Delivery System Market Share by Type: 2025 vs 2032
Figure 4. Viral Gene Delivery System Features
Figure 5. Non-viral Gene Delivery System Features
Figure 6. Global Gene Delivery System Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Gene Delivery System Market Share by Application: 2025 vs 2032
Figure 8. Neurological Diseases Case Studies
Figure 9. Cancer Case Studies
Figure 10. Others Case Studies
Figure 11. Gene Delivery System Report Years Considered
Figure 12. Global Gene Delivery System Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 13. Global Gene Delivery System Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Gene Delivery System Market Share by Region: 2025 vs 2032
Figure 15. Global Gene Delivery System Market Share by Players in 2025
Figure 16. Global Gene Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by Gene Delivery System Revenue in 2025
Figure 18. North America Gene Delivery System Market Size YoY Growth (US$ Million), 2021–2032
Figure 19. North America Gene Delivery System Market Share by Country (2021–2032)
Figure 20. United States Gene Delivery System Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. Canada Gene Delivery System Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Europe Gene Delivery System Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Gene Delivery System Market Share by Country (2021–2032)
Figure 24. Germany Gene Delivery System Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. France Gene Delivery System Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. U.K. Gene Delivery System Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Italy Gene Delivery System Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Russia Gene Delivery System Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Ireland Gene Delivery System Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Asia-Pacific Gene Delivery System Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Gene Delivery System Market Share by Region (2021–2032)
Figure 32. China Gene Delivery System Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Japan Gene Delivery System Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. South Korea Gene Delivery System Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Southeast Asia Gene Delivery System Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. India Gene Delivery System Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Australia & New Zealand Gene Delivery System Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Latin America Gene Delivery System Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Gene Delivery System Market Share by Country (2021–2032)
Figure 40. Mexico Gene Delivery System Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Brazil Gene Delivery System Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Middle East & Africa Gene Delivery System Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Gene Delivery System Market Share by Country (2021–2032)
Figure 44. Israel Gene Delivery System Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Saudi Arabia Gene Delivery System Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. UAE Gene Delivery System Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Biogen Revenue Growth Rate in Gene Delivery System Business (2021–2026)
Figure 48. Novartis Revenue Growth Rate in Gene Delivery System Business (2021–2026)
Figure 49. Gilead Sciences Revenue Growth Rate in Gene Delivery System Business (2021–2026)
Figure 50. Sarepta Therapeutics Revenue Growth Rate in Gene Delivery System Business (2021–2026)
Figure 51. Alnylam Pharmaceuticals Revenue Growth Rate in Gene Delivery System Business (2021–2026)
Figure 52. Amgen Revenue Growth Rate in Gene Delivery System Business (2021–2026)
Figure 53. Spark Therapeutics Revenue Growth Rate in Gene Delivery System Business (2021–2026)
Figure 54. Akcea Therapeutics Revenue Growth Rate in Gene Delivery System Business (2021–2026)
Figure 55. Sunway Biotech Revenue Growth Rate in Gene Delivery System Business (2021–2026)
Figure 56. SIBIONO Revenue Growth Rate in Gene Delivery System Business (2021–2026)
Figure 57. AnGes Revenue Growth Rate in Gene Delivery System Business (2021–2026)
Figure 58. Orchard Therapeutics Revenue Growth Rate in Gene Delivery System Business (2021–2026)
Figure 59. Human Stem Cells Institute Revenue Growth Rate in Gene Delivery System Business (2021–2026)
Figure 60. Adaptimmune Revenue Growth Rate in Gene Delivery System Business (2021–2026)
Figure 61. Krystal Biotech Revenue Growth Rate in Gene Delivery System Business (2021–2026)
Figure 62. Vertex Pharmaceuticals Revenue Growth Rate in Gene Delivery System Business (2021–2026)
Figure 63. CSL Behring Revenue Growth Rate in Gene Delivery System Business (2021–2026)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
